Phase 2 study of first‐line pembrolizumab monotherapy in elderly patients with non‐small‐cell lung cancer expressing high PD‐L1
暂无分享，去创建一个
N. Hattori | M. Yamasaki | T. Masuda | K. Fujitaka | N. Ishikawa | K. Hamai | R. Nishino | K. Masuda | N. Matsumoto | R. Kawano | K. Yamaguchi | S. Sakamoto | Tomoko Suzuki | Mirai Matsumura | Shoko Isoyama | Sayaka Ueno | Mineyo Mito